The Clinicopathological Characteristics of Gastric Cancer and Precancerous Conditions in Gastric DLBCL and MALT Lymphoma Patients: a Multi-center Retrospective Study

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2023 May 15

PMID 37183786

Authors

Yun Feng

Tian-Jiao Duan

Qing Huang

Zhi-Yi Li

Ya-Ping Liu

Miao-Sha Luo

Gui-Fang Lu

Wen Shi

Zhi-Yong Zhang

Hong-Xia Li

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study is to explore the clinicopathological characteristics of gastric cancer and precancerous conditions in patients with primary gastric lymphoma.

Methods: We analyzed 474 cases of primary gastric lymphoma, mainly DLBCL and MALT, from three clinical centres retrospectively, and compared the clinicopathological parameters of primary gastric lymphoma patients complicated with gastric cancer, precancerous conditions, or with no complications.

Results: A total of 5.1% of the patients with primary gastric lymphoma were diagnosed with gastric cancer, including metachronous gastric adenocarcinoma (3.2%) and synchronous gastric adenocarcinoma (1.9%). Of the patients with gastric lymphoma, 14.6% had precancerous conditions including atrophy (14.6%), intestinal metaplasia (8.9%), and low-grade intraepithelial neoplasia (1.9%). Primary gastric lymphoma patients with an ulcerative type ( = 0.009) and Lugano classification stage IIE + IV ( < 0.001) lymphoma had a higher risk of complicating with gastric cancers or precancerous conditions. The rate of infection of (Hp) was 68.4% in patients with primary gastric lymphoma, which was higher in patients with MALT lymphoma ( < 0.001), Lugano classification stage I + II ( < 0.001), and patients complicated with precancerous conditions and gastric cancer ( < 0.001), especially gastric cancer of the intestinal type ( = 0.04). Gastric cancer (95.8%) and precancerous conditions (91.3%) occurred mostly in Hp-infected primary gastric lymphoma patients, with a minor subset of Hp-eradicated patients. Primary gastric lymphoma patients had a higher detection rate of early gastric cancer (25.0%) and a five-year survival rate (40.0%) than the general Chinese population.

Conclusions: Patients with primary gastric lymphoma have a high risk of developing gastric cancer and precancerous conditions, and this risk may be related to infection. Follow-up of primary gastric lymphoma provides an opportunity for the detection of early gastric cancer.Key messages5.1% of the patients with primary gastric lymphoma were diagnosed with gastric cancer.14.6% of the patients with gastric lymphoma had premalignant lesions including atrophy (14.6%), intestinal metaplasia (8.9%), and low-grade intraepithelial neoplasia (1.9%).Primary gastric lymphoma patients complicating with gastric cancer had a higher infection rate of (100.0%), a detection rate of early gastric cancer (25.0%) and a five-year survival rate (40.0%) than the general Chinese population.

Citing Articles

Epstein-Barr Virus (EBV) and Human Papilloma Virus (HPV) in Gastric Cancers, with Special Reference to Gastric Cancer at a Young Age-A Pilot Study in Poland.

Mazurek M, Jaros M, Gliwa A, Sitarz M, Dudzinska E, Zinkiewicz K Int J Mol Sci. 2025; 26(2).

PMID: 39859425 PMC: 11765604. DOI: 10.3390/ijms26020711.

The oral-gut microbiome axis in breast cancer: from basic research to therapeutic applications.

Huang L, Jiang C, Yan M, Wan W, Li S, Xiang Z Front Cell Infect Microbiol. 2024; 14():1413266.

PMID: 39639864 PMC: 11617537. DOI: 10.3389/fcimb.2024.1413266.

Transformed gastric mucosa-associated lymphoid tissue lymphoma originating in the colon and developing metachronously after eradication: A case report.

Saito M, Tanei Z, Tsuda M, Suzuki T, Yokoyama E, Kanaya M World J Gastrointest Oncol. 2024; 16(10):4281-4288.

PMID: 39473962 PMC: 11514681. DOI: 10.4251/wjgo.v16.i10.4281.

Construction and validation of the prognostic nomogram model for patients with diffuse-type gastric cancer based on the SEER database.

Huang T, Chan C, Zhou H, Hu K, Wang L, Ye Z Discov Oncol. 2024; 15(1):305.

PMID: 39048774 PMC: 11269533. DOI: 10.1007/s12672-024-01180-0.

Association of oxidative balance score with Helicobacter pylori infection and mortality among US population.

Peng L, Sun Y, Zhu Z, Li Y Eur J Nutr. 2024; 63(7):2499-2509.

PMID: 38847866 DOI: 10.1007/s00394-024-03445-4.

References

Sugimoto M, Kajimura M, Sato Y, Hanai H, Kaneko E, Kobayashi H . Regression of primary gastric diffuse large B-cell lymphoma after eradication of Helicobacter pylori. Gastrointest Endosc. 2001; 54(5):643-5. DOI: 10.1067/mge.2001.118647. View

Kuo S, Yeh K, Wu M, Lin C, Hsu P, Wang H . Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood. 2012; 119(21):4838-44. DOI: 10.1182/blood-2012-01-404194. View

Strong V, Wu A, Selby L, Gonen M, Hsu M, Song K . Differences in gastric cancer survival between the U.S. and China. J Surg Oncol. 2015; 112(1):31-7. PMC: 4667726. DOI: 10.1002/jso.23940. View

Huang R, Choi A, Truong C, Yeh M, Hwang J . Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions. Gut Liver. 2019; 13(6):596-603. PMC: 6860040. DOI: 10.5009/gnl19181. View

Correa P . Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24):6735-40. View

Rentien A, Levy M, Copie-Bergman C, Gagniere C, Dupuis J, Le Baleur Y . Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma. Dig Liver Dis. 2017; 50(2):181-188. DOI: 10.1016/j.dld.2017.10.014. View

Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F . Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13. PMC: 4019373. DOI: 10.1158/1055-9965.EPI-13-1057. View

Tari A, Asaoku H, Kashiwado K, Yoshino T, Kitadai Y, Tanaka S . Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication. Dig Endosc. 2009; 21(4):219-27. DOI: 10.1111/j.1443-1661.2009.00896.x. View

Carson H . Unexpected synchronous non-Hodgkin's lymphoma encountered during the treatment of a previously-diagnosed carcinoma: report of three cases. Leuk Lymphoma. 1996; 23(5-6):625-9. DOI: 10.3109/10428199609054875. View

10.

. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2019; 5(1):42-54. PMC: 7033564. DOI: 10.1016/S2468-1253(19)30328-0. View

11.

Ma Z, Fang M, Huang Y, He L, Chen X, Liang C . CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma. Eur J Radiol. 2017; 91:142-147. DOI: 10.1016/j.ejrad.2017.04.007. View

12.

Lamarque D, Levy M, Chaumette M, Roudot-Thoraval F, Cavicchi M, Auroux J . Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma. Am J Gastroenterol. 2006; 101(8):1886-93. DOI: 10.1111/j.1572-0241.2006.00671.x. View

13.

Liu Z, Lu S, Li X, Chen H, Chen H, Chen X . Endoscopic, clinicopathological, and growth characteristics of minute gastric cancer. J Dig Dis. 2022; 23(11):628-635. DOI: 10.1111/1751-2980.13139. View

14.

Xirouchakis E, Laoudi F, Tsartsali L, Spiliadi C, Georgopoulos S . Screening for gastric premalignant lesions with narrow band imaging, white light and updated Sydney protocol or both?. Dig Dis Sci. 2012; 58(4):1084-90. DOI: 10.1007/s10620-012-2431-x. View

15.

Shah S, Piazuelo M, Kuipers E, Li D . AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology. 2021; 161(4):1325-1332.e7. PMC: 8740554. DOI: 10.1053/j.gastro.2021.06.078. View

16.

Buxbaum J, Hormozdi D, Dinis-Ribeiro M, Lane C, Dias-Silva D, Sahakian A . Narrow-band imaging versus white light versus mapping biopsy for gastric intestinal metaplasia: a prospective blinded trial. Gastrointest Endosc. 2017; 86(5):857-865. DOI: 10.1016/j.gie.2017.03.1528. View

17.

Capelle L, den Hoed C, de Vries A, Biermann K, Casparie M, Meijer G . Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case-control study. Eur J Gastroenterol Hepatol. 2011; 24(1):42-7. DOI: 10.1097/MEG.0b013e32834d85e6. View

18.

DAWSON I, Cornes J, MORSON B . Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961; 49:80-9. DOI: 10.1002/bjs.18004921319. View

19.

Amiot A, Jooste V, Gagniere C, Levy M, Copie-Bergman C, Dupuis J . Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma. 2017; 58(9):1-11. DOI: 10.1080/10428194.2017.1283033. View

20.

Zullo A, Rago A, Felici S, Licci S, Ridola L, di Toritto T . Onset and Progression of Precancerous Lesions on Gastric Mucosa of Patients Treated for Gastric Lymphoma. J Gastrointestin Liver Dis. 2020; 29(1):27-31. DOI: 10.15403/jgld-516. View